Pfizer loses blockbuster Epilepsy drug patent fight in UK Supreme Court Medical Dialogues Bureau15 Nov 2018 11:42 AM ISTThe expiry of the basic patent on Lyrica five years ago had allowed generic drugmakers to launch cut-price versions of Pfizer's medicine, which...
Suven Life Sciences gets Product Patents in Australia and Hong Kong Medical Dialogues Bureau15 Nov 2018 11:30 AM ISTHyderabad: Suven Life Science Ltd has recently announced that the grant of one product patent from Australia and one product patent from Hong Kong...
Zydus gets USFDA nod for Arsenic Trioxide Injection Medical Dialogues Bureau15 Nov 2018 11:05 AM ISTNew Delhi: Zydus Cadila has received the final approval from the USFDA to market Arsenic Trioxide Injection, 10 mg/10 mL (1 mg/mL) single-dose vial...
Cipla's subsidiary to acquire US-based Avenue Therapeutics for Rs 156 Crore Medical Dialogues Bureau15 Nov 2018 9:55 AM ISTNew Delhi: Drug major Cipla has recently announced its subsidiary InvaGen Pharmaceuticals Inc has entered into definitive agreements to acquire...
Aurobindo Pharma shares fall 3% after Q2 earnings Medical Dialogues Bureau15 Nov 2018 9:45 AM ISTNew Delhi: Shares of Aurobindo Pharma has recently fallen almost 3 per cent after the company reported 21.70 per cent dip in consolidated net profit...
Lupin launches Generic Pneumonia Drug Atovaquone Oral Suspension USP in US Medical Dialogues Bureau14 Nov 2018 3:00 PM ISTNew Delhi: Drug giant Lupin has recently launched the generic Atovaquone oral suspension USP, which is used for the prevention and treatment of...
Aurobindo to acquire under development product, related assets from Advent for Rs 90 crore Medical Dialogues Bureau14 Nov 2018 2:55 PM ISTNew Delhi: Drug firm Aurobindo Pharma has recently stated that its arm in the USA has signed a pact to acquire an under-development product and...
Sun Pharma Q2 consolidated net loss at Rs 219 crore Medical Dialogues Bureau14 Nov 2018 12:00 PM ISTNew Delhi: Drug giant Sun Pharmaceutical Industries (Sun Pharma) has reported a consolidated net loss of Rs 218.82 crore for the July-September...
Roche's Tecentriq gets instant FDA review in tough-to-treat breast cancer Medical Dialogues Bureau14 Nov 2018 10:00 AM ISTZURICH: As the Swiss drugmaker seeks to be the first company to have its immunotherapy win approval in this indication, Roche's Tecentriq medicine...
Glenmark teams up with South Korean firm SCD for ophthalmic products Medical Dialogues Bureau14 Nov 2018 9:36 AM ISTNew Delhi: To develop, manufacture and market a portfolio of ophthalmic products in the US and Canada, drug major Glenmark Pharmaceuticals has entered...
Theravance, Mylan win USFDA approval for COPD Drug Yupelri Medical Dialogues Bureau14 Nov 2018 9:00 AM ISTNew Delhi: Mylan has recently announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Yupelri...
Lupin gets EIR from USFDA for its Nagpur facility Medical Dialogues Bureau13 Nov 2018 3:55 PM ISTNew Delhi: Drug firm Lupin Monday said it has received an establishment inspection report(EIR) from the US health regulator post the inspection of its...
